Use of PET-DT prior to curative treatment in lung cancer, proportion (%) - Target level ≥ 82

Proportion of patients with stage IB-IIIB NSCLC who have undergone PET-DT (positron emission tomography combined with computed tomography) prior to planned curative treatment (surgery, primary chemotherapy or stereotactic radiotherapy). A curative treatment aims to cure the disease, unlike treatments that aim to prolong life or reduce symptoms and/or pain.